Dexamethasone Ear Solution Clinical Trials

• Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
  Multiple Myeloma
  
• Gemcitabine, Dexamethasone and Cisplatin Versus Dexamethasone, Cytarabine, Cisplatin in Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089817 - Recruiting
  Lymphoma
  
• Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone,Plus Systemic Dexamethasone
  ClinicalTrials.gov Identifier: NCT00519584 - Recruiting
  Pain
  
• A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00424047 - Active, not recruiting
  Multiple Myeloma
  
• Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00344422 - Active, not recruiting
  M-Protein; Multiple Myeloma; Myeloma; Myeloma Proteins
  
• IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00200681 - Recruiting
  Multiple Myeloma
  
• Phase 1/2 Study of VELCADE®, Dexamethasone, and Revlimid® Versus VELCADE, Dexamethasone, Cyclophosphamide, and Revlimid in Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00507442 - Recruiting
  Multiple Myeloma
  
• Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
  ClinicalTrials.gov Identifier: NCT00522392 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
  ClinicalTrials.gov Identifier: NCT00390598 - Active, not recruiting
  Colonoscopy
  
• Dexamethasone 0.01% Solution for the Treatment of Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00111072 - Completed
  
  
• Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00176293 - Active, not recruiting
  Prostate Cancer
  
• CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00056160 - Active, not recruiting
  Multiple Myeloma
  
• Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00151203 - Active, not recruiting
  Multiple Myeloma
  
• A Comparison of GV Mouth Washes,Nystatin,Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
  ClinicalTrials.gov Identifier: NCT00128323 - Active, not recruiting
  Oropharyngeal candidiasis
  
• Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00116961 - Active, not recruiting
  Multiple Myeloma
  
• A Pilot Study of Combination Therapy with VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00135187 - Active, not recruiting
  Multiple Myeloma
  
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00458705 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• A Multicenter, Open-Label, Single-Arm, Expanded Access Program For Lenalidomide Plus Dexamethasone In Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00179647 - Recruiting
  Multiple Myeloma
  
• A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea.
  ClinicalTrials.gov Identifier: NCT00272285 - Active, not recruiting
  Vomiting; Nausea
  
• Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00441168 - Recruiting
  Multiple Myeloma
  
• PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See If It Protects Their Babies From Ear Disease
  ClinicalTrials.gov Identifier: NCT00310349 - Not yet recruiting
  Middle Ear Effusion; Tympanic Membrane Perforation; Acute Otitis Media; Streptococcus Pneumoniae
  
• The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00119002 - Recruiting
  Bronchiolitis, Viral
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
  primary systemic amyloidosis
  
• Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11
  ClinicalTrials.gov Identifier: NCT00365092 - Completed
  Otitis Media; Middle Ear Effusion
  
• Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00547053 - Recruiting
  Cystic Fibrosis
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Genetics of Middle Ear Disease
  ClinicalTrials.gov Identifier: NCT00422136 - Active, not recruiting
  Otitis Media
  
• Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074191 - Active, not recruiting
  intraocular lymphoma; primary central nervous system lymphoma
  
• Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074178 - Active, not recruiting
  primary central nervous system lymphoma; intraocular lymphoma
  
• Dexamethasone Study
  ClinicalTrials.gov Identifier: NCT00152867 - Recruiting
  Cancer; Quality of Life; Emesis
  
• Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00089167 - Active, not recruiting
  primary systemic amyloidosis
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease
  ClinicalTrials.gov Identifier: NCT00222417 - Active, not recruiting
  Otosclerosis; Tympanic Membrane Perforation
  
• Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
  ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
  
• Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00030069 - Recruiting
  Myelodysplastic Syndromes
  
• Aprepitant, Ondansetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00248547 - Active, not recruiting
  Cancer
  
• Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00577993 - Active, not recruiting
  Lymphoma
  
• Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00250926 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00017069 - Active, not recruiting
  refractory plasma cell neoplasm; stage II multiple myeloma; stage III multiple myeloma
  
• Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
  ClinicalTrials.gov Identifier: NCT00437229 - Active, not recruiting
  Healthy Adult Volunteer
  
• A Multicentre, Single-Arm, Open-Label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00420849 - Active, not recruiting
  Multiple Myeloma
  
• Dexamethasone or Dexamethasone in Combination with Thalidomide as Salvage Therapy
  ClinicalTrials.gov Identifier: NCT00083902 - Completed
  Multiple Myeloma
  
• Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00227682 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Dexamethasone for Palliation - Brain Metastases
  ClinicalTrials.gov Identifier: NCT00188864 - Recruiting
  Neoplasm Metastasis
  
• Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.
  ClinicalTrials.gov Identifier: NCT00204165 - Active, not recruiting
  Magnetic Resonance Imaging, Intestine Small, Crohn Disease.
  
• A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00478777 - Active, not recruiting
  Relapsed or Refractory Multiple Myeloma
  
• Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00375791 - Active, not recruiting
  Multiple Myeloma
  
• Dexamethasone for Symptom Burden in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00489307 - Recruiting
  Solid Tumors
  
• Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
  ClinicalTrials.gov Identifier: NCT00442312 - Active, not recruiting
  Glaucoma
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Bortezomib-Dexamethasone-Doxorubicin-Study
  ClinicalTrials.gov Identifier: NCT00401804 - Recruiting
  Multiple Myeloma; Renal Insuficiency
  
• Middle Ear Pressure Disregulation After Tympanostomy Tube Insertion
  ClinicalTrials.gov Identifier: NCT00393900 - Recruiting
  Otitis Media With Effusion
  
• Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00084864 - Recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Total Therapy II
  ClinicalTrials.gov Identifier: NCT00083551 - Active, not recruiting
  Multiple Myeloma
  
• Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica
  ClinicalTrials.gov Identifier: NCT00516009 - Recruiting
  RADICULAR PAIN
  
• Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System
  ClinicalTrials.gov Identifier: NCT00205881 - Recruiting
  Hearing Loss
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003397 - Active, not recruiting
  Lymphoma
  
• Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns with Lupus
  ClinicalTrials.gov Identifier: NCT00007358 - Recruiting
  Congenital heart block; Neonatal lupus; Atrioventricular nodal dysfunction; Myocardial injury
  
• Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00261612 - Active, not recruiting
  Lymphoma, Mantle-Cell
  
• Drugs to Reduce the Side Effects of Chemotherapy
  ClinicalTrials.gov Identifier: NCT00003213 - Active, not recruiting
  solid tumor; Nausea; Vomiting
  
• Randomized Study of Albendazole in Patients with Epilepsy Due to Neurocysticercosis
  ClinicalTrials.gov Identifier: NCT00004403 - Active, not recruiting
  Epilepsy; Cysticercosis
  
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
  ClinicalTrials.gov Identifier: NCT00370747 - Active, not recruiting
  Dry Eye Syndromes
  
• Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
  ClinicalTrials.gov Identifier: NCT00405730 - Active, not recruiting
  Cataract Surgery
  
• Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00424398 - Active, not recruiting
  Conjunctivitis, Allergic
  
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
  Lymphoma; Leukemia
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003402 - Active, not recruiting
  Lymphocytic Lymphoma
  
• Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00258245 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00333918 - Active, not recruiting
  Pain; Inflammation
  
• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00357279 - Active, not recruiting
  Cystic Fibrosis
  
• Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00423007 - Active, not recruiting
  Allergic Conjunctivitis
  
• Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
  ClinicalTrials.gov Identifier: NCT00042367 - Active, not recruiting
  Brain Tumors
  
• Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of PVR
  ClinicalTrials.gov Identifier: NCT00370760 - Recruiting
  Proliferative Vitreoretinopathy
  
• Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00564889 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00241319 - Active, not recruiting
  Allergic Conjunctivitis
  
• Velcade and Dexamethasone in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00391157 - Active, not recruiting
  Multiple Myeloma
  
• Efficacy and Safety of 28 or 56 Days Treatment With Inhaled Tobramycin Nebuliser Solution for Pseudomonas Aeruginosa Infection in Children With Cystic Fibrosis.
  ClinicalTrials.gov Identifier: NCT00391976 - Active, not recruiting
  Cystic Fibrosis
  
• Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
  ClinicalTrials.gov Identifier: NCT00492284 - Recruiting
  Choroidal Neovascularization; Macular Degeneration
  
• Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00244543 - Active, not recruiting
  Allergic Conjunctivitis
  
• Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00364091 - Active, not recruiting
  Allergic Conjunctivitis
  
• DTPACE followed by Tandem Transplant with MEL 200 versus MEL/DTPACE Hybrid and DTPACE Consolidation
  ClinicalTrials.gov Identifier: NCT00083915 - Active, not recruiting
  Multiple Myeloma
  
• A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea
  ClinicalTrials.gov Identifier: NCT00578773 - Recruiting
  Acute Otitis Media Requiring Ear Tubes
  
• Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars
  ClinicalTrials.gov Identifier: NCT00469235 - Recruiting
  Keloid
  
• Phase 2 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive ALL
  ClinicalTrials.gov Identifier: NCT00130195 - Active, not recruiting
  Acute Lymphoblastic Leukemia
  
• Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c
  ClinicalTrials.gov Identifier: NCT00422851 - Recruiting
  Healthy
  
• Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
  ClinicalTrials.gov Identifier: NCT00520767 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
  ClinicalTrials.gov Identifier: NCT00561301 - Recruiting
  Lymphoma
  
• Rituximab and Dexamethasone in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00244855 - Recruiting
  Lymphoma
  
• Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00213226 - Recruiting
  Bronchiolitis
  
• The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery
  ClinicalTrials.gov Identifier: NCT00236223 - Recruiting
  Pain, Postoperative
  
• To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
  ClinicalTrials.gov Identifier: NCT00372294 - Recruiting
  Toxoplasmic Chorioretinitis
  
• Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Having a Tonsillectomy
  ClinicalTrials.gov Identifier: NCT00378547 - Recruiting
  Pain, Postoperative
  
• High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
  ClinicalTrials.gov Identifier: NCT00451594 - Recruiting
  Idiopathic Thrombocytopenic Purpura